 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ICICI Securities recommended hold rating on Metropolis Healthcare with a target price of Rs 1440 in its research report dated August 04, 2023.

Hold Metropolis Healthcare; target of Rs 1440: ICICI Securities

Metropolis Consolidated June 2023 Net Sales at Rs 277.09 crore, down 0.99% Y-o-Y

Revenues from core business grew by 12% on a year-on-year basis to Rs 271 crore.

Metropolis Healthcare edges up despite 13.8% decline in Q1 net profit

Saurabh Mukherjea of Marcellus Investment Managers has also been consistently adding the stock in his Little Champs Portfolio, which focuses on investing in quality midcap and small-cap companies for a long term.

Metropolis Healthcare gains 2% as Q1 core business revenue grows 12%

YES Securities is bullish on Metropolis Healthcare has recommended buy rating on the stock with a target price of Rs 1520 in its research report dated May 17, 2023.

Buy Metropolis Healthcare; target of Rs 1520: YES Securities

Metropolis Standalone March 2023 Net Sales at Rs 264.41 crore, up 21.29% Y-o-Y

Metropolis Consolidated March 2023 Net Sales at Rs 282.55 crore, down 7.63% Y-o-Y

YES Securities is bullish on Metropolis Healthcare has recommended buy rating on the stock with a target price of Rs 1720 in its research report dated February 14, 2023.

Buy Metropolis Healthcare; target of Rs 1720: YES Securities

More details are awaited, but Metropolis stock plunged over 5%

I-T searches at Metropolis Path Labs office in Mumbai, say sources

Backed by deep-pocketed venture capitalists and private equity funds, health technology startups have sprouted in the diagnostics sector over the past five years, hoping to disrupt the existing status quo through low-cost testing procedures

Diagnostic giant warns cash-burning startups they have got it all wrong

Metropolis Healthcare Ltd. owns and operates medical laboratories. The firm operates through Pathology Services. It offers comprehensive testing in the areas of genetics biochemistry, molecular oncology, anatomic pathology, microbiology, hematology, and immunochemistry. The company was founded by Sushil Kanubhai Shah and Gomathi Babu Sadacharam Kulandai Velu in 1981 and is headquartered in Mumbai, India.

Watchers	73
52-Wk Low	1,171.35
52-Wk High	1,791.20

Market Cap	71.9B
Volume (M)	372,280.00
52-Wk High	1,791.20
52-Wk Low	1,171.35

Current Price	1,459.80
Prev Close	1,403.80
Open	1,406.50
Dividend Yield	N/A
50-Day Moving Average	1,393.52
Beta	0.09
Avg. Volume	278,053.73
PE Ratio	51.98

52-Week High	1,791.20
52-Week Low	1,171.35
Market Capitalization	71.9B
EPS	27.01
Price to Book	7.27
Revenue Per Employee	2.4M
Enterprise Value/EBITDA	23.28

METROPOLIS.NSE Metropolis Healthcare Ltd.

About

Feed

News

Sentiment

Fundamentals